Biodesix, Inc. provided revenue guidance for the year 2024. The company anticipates generating between $65 million to $68 million in total revenue in 2024, representing an approximate 32% to 39% year-over-year growth rate.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.565 USD | -0.32% | +4.68% | -14.95% |
May. 13 | TD Cowen Starts Biodesix With Buy Rating, $2.80 Price Target | MT |
May. 08 | Transcript : Biodesix, Inc., Q1 2024 Earnings Call, May 08, 2024 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-14.95% | 178M | |
-22.04% | 8.54B | |
+66.93% | 4.32B | |
-0.82% | 2.53B | |
-39.22% | 2.48B | |
-8.53% | 1.9B | |
-17.46% | 1.59B | |
-40.70% | 1.23B | |
+13.38% | 1.13B | |
+16.15% | 994M |
- Stock Market
- Equities
- BDSX Stock
- News Biodesix, Inc.
- Biodesix, Inc. Provides Revenue Guidance for the Year 2024